- CONTACT US
- AFS
- Business
- Bussiness
- Car
- Career
- Celebrity
- Digital Products
- Education
- Entertainment
- Fashion
- Film
- Food
- Fun
- Games
- General Health
- Health
- Health Awareness
- Healthy
- Healthy Lifestyle
- History Facts
- Household Appliances
- Internet
- Investment
- Law
- Lifestyle
- Loans&Mortgages
- Luxury Life Style
- movie
- Music
- Nature
- News
- Opinion
- Pet
- Plant
- Politics
- Recommends
- Science
- Self-care
- services
- Smart Phone
- Sports
- Style
- Technology
- tire
- Travel
- US
- World

Dec 3 (Reuters) - Lockheed Martin said on Wednesday it has opened a hypersonics system integration lab at its Huntsville campus as it pushes to develop next-generation weapons.
Hypersonic weapons, which can travel at more than five times the speed of sound and evade traditional defenses, are at the centre of an arms race between the United States and China.
Lockheed's 17,000-square-foot facility will include advanced test equipment, simulation tools and an integration environment.
It is part of a larger capital program that now totals roughly $529 million and includes 719,000 square feet of facilities under construction or planned, the company said.
"Hypersonic weapons are reshaping the future of military defense by delivering unmatched speed and maneuverability that outpace traditional threats," said Holly Molmer, program management director for Lockheed Martin
In October, defense start-up Castelion said it won contracts to integrate its Blackbeard hypersonic strike weapon with current U.S. Army systems.
(Reporting by Aishwarya Jain in Bengaluru; Editing by Shailesh Kuber)
LATEST POSTS
- 1
What did the gov’t approve for Israel’s 2026 state budget? - 2
Benin coup thwarted by loyalist troops, president tells nation - 3
Merz visit highlights new strategic, and strained, Germany-Israel bond - 4
2025 Arctic League telethon raises more than $39k - 5
'We need everyone,' wounded reservist urges Knesset panel to advance haredi draft law
Wizz CEO: We’re going to invest $1 b. in Israeli market
US FDA approves Kura-Kyowa's blood cancer therapy
Novo Nordisk cuts Wegovy price as CEO pledges to go 'all in' on weight loss pill
Europe's powerful Ariane 6 rocket launches Sentinel-1D Earth-observation satellite to orbit (video)
FDA adds strongest warning to Sarepta gene therapy linked to 2 patient deaths
Qantas and Virgin Australia Ban Power Bank Usage on Flights Following Safety Incidents
Amazon sued over 'punitive' handling of employee absences
Merck sees over $5 billion opportunity in Cidara's experimental flu drug
Shah Capital pushes for Novavax sale, warns of proxy fight













